O
SIBN icon

OrbiMed’s SI-BONE Inc SIBN Stock Holding History

OrbiMed’s Portfolio SIBN Stock Details SIBN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-250,000
Closed -$3.5M – 124
2024
Q4 		$3.5M Hold
250,000
– – 0.07% 94
2024
Q3 		$3.5M Hold
250,000
– – 0.06% 104
2024
Q2 		$3.23M Hold
250,000
– – 0.06% 96
2024
Q1 		$4.09M Buy
+250,000
New +$4.71M 0.08% 99

Other funds holding SIBN

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

OrbiMed's SIBN Position: Q4 2025 in Review

OrbiMed sold out of SI-BONE Inc (SIBN) in Q4 2025, closing a stake of 2,578,979 shares — an estimated $38M sold.

OrbiMed first reported a position in SIBN in Q4 2018 and held it in 27 quarters. The position peaked at $70.9M in Q1 2022. 182 funds tracked by Wall St. Rank hold SIBN as of Q4 2025.

  • OrbiMed reported no remaining SI-BONE Inc position as of Q4 2025 after selling out during the quarter.
  • OrbiMed sold 2,578,979 SI-BONE Inc shares in Q4 2025, an estimated $38M.
  • OrbiMed first reported a position in SI-BONE Inc in Q4 2018 and held it in 27 quarters.
  • OrbiMed's SI-BONE Inc position peaked at $70.9M in Q1 2022.
  • 182 funds tracked by Wall St. Rank held SI-BONE Inc as of Q4 2025.

Based on OrbiMed's 13F filing for Q4 2025, filed 17 Feb 2026.